Molecules designed to interfere with DNA upon signal

Blacksburg, Va., March 24, 2003 -- Medical science's arsenal against cancer includes compounds that interfere with the DNA of cancer cells. However, these medicines often damage noncancer cells as well, making chemotherapy a sickening treatment. Many scientists are trying to develop compounds that can be released upon command in the presence of disease cells. Now, Virginia Tech researchers have developed a new molecule that early results show can be signaled to bind to target DNA and stop replication.

Karen Brewer, professor of chemistry at Virginia Tech, will present the research at the 225th national meeting of the American Chemical Society March 23-27 in New Orleans.

Brewer, whose group develops mixed-metal supramolecular complexes for a wide assortment of molecular devices, has been working for sometime on DNA binding agents and photo initiated DNA cleavage agents. At the meeting, she will talk about interactions with DNA using a complex of molecules with functions that allow it to bind to DNA and to stop replication.

"This is a new class of molecules," says Brewer. "The complex does not become toxic until it receives a light signal, at which point it cleaves the DNA so that it cannot replicate."

Results in test tubes and under the microscope with different cell lines have demonstrated that the specially constructed molecules can kill cells in the presence of light.

The researchers have applied for a patent through Virginia Tech Intellectual Properties Inc. (www.vtip.org). The technology has been licensed to Carilion Biomedical Institute of Roanoke, Va.

The poster, "Mixed-metal supramolecular complexes as photochemical molecular devices and DNA binding and photocleavage agents (Inor 357)," coauthored by Brewer, Alvin A. Holder of the University of West Indies, and R. Lee Williams, Shawn M. Swavey, and Mark Elvington, all of Virginia Tech, will be presented as part of the Coordination Chemistry session of the Divisi

Contact: Karen Brewer
Virginia Tech

Page: 1 2

Related biology news :

1. Molecules discovered that extend life in yeast, human cells
2. Designer Molecules: Largest Protein Ever Created From Scratch Has Implications For Novel Drug Delivery And Diagnostics
3. NYU And Rockefeller Scientists Design Molecules That Stymie A Notorious Bug
4. Synthetic Lock Binds Some Molecules, Excludes Others
5. UCSF Team Identifies Two Key Molecules In Asthma; Important Finding For New Therapies That Treat Disease At Cell Level
6. NYU Researchers Develop Simple, Predictable And Precise Technique For Arranging DNA Molecules Into Two-Dimensional Crystals
7. Virginia Tech Scientists Study Killer Molecules
8. Researcher Gains 30,000% Saving Using "Bargain Basement" Chemistry To Create Complex Industrially Useful Molecules
9. Biosensor Is A Model For Widespread Testing Of Chemicals, Molecules
10. Moving DNA Molecules With Magnetic Tweezers
11. Newly designed nanoparticle quantum dots simultaneously target and image prostate tumors in mice

Post Your Comments:

(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 8.8% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... SARASOTA, FL (PRWEB) , ... ... ... Inc. (RPS®) today announces publication of a United States multicenter, prospective clinical ... single use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
Cached News: